IL6 and endometrial cancer: Dossus et al18 conducted a nested case‐control study of patients with endometrial cancer to determine the risk of endometrial cancer, and they found that the inflammation factor cytokines (especially IL‐6, TNF receptor, and C peptide) had an odds ratio of 1.62 for developing endometrial cancer.